ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
The T-cell-specific cell-surface receptors CD28 and CTLA-4 are important regulators of the immune system. CD28 potently enhances those T-cell functions that are essential for an effective antigen-specific immune response, and the homologous CTLA-4 counterbalances the CD28-mediated signals and thus prevents an otherwise fatal overstimulation of the lymphoid system. Here we report the identification of a third member of this family of molecules, inducible co-stimulator (ICOS), which is a homodimeric protein of relative molecular mass 55,000-60,000 (M(r) 55K-60K). Matching CD28 in potency, ICOS enhances all basic T-cell responses to a foreign antigen, namely proliferation, secretion of lymphokines, upregulation of molecules that mediate cell-cell interaction, and effective help for antibody secretion by B cells. Unlike the constitutively expressed CD28, ICOS has to be de novo induced on the T-cell surface, does not upregulate the production of interleukin-2, but superinduces the synthesis of interleukin-10, a B-cell-differentiation factor. In vivo, ICOS is highly expressed on tonsillar T cells, which are closely associated with B cells in the apical light zone of germinal centres, the site of terminal B-cell maturation. Our results indicate that ICOS is another major regulator of the adaptive immune system.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Immune co-stimulator (ICOS) is a co-stimulatory molecule expressed on T cells, which enhances function and expansion of CD8+ T cells and Tregs (Fu et al., 2011; Hutloff et al., 1999; Liakou et al., 2008).”
From Hallmarks of response, resistance, and toxicity to immune checkpoint blockade (2021) · cites this paper as Hutloff et al., 1999
Citations
Cites
Cordell, J. L., Falini, B., Erber, W. N., Ghosh, A. K., Abdulaziz, Z., MacDonald, S., Pulford, K. A., Stein, H., & Mason, D. Y. (1984) · Journal of Histochemistry & Cytochemistry · doi:10.1177/32.2.6198355 · Cited by 3,148
Tivol, E. A., Borriello, F., Schweitzer, A. N., Lynch, W. P., Bluestone, J. A., & Sharpe, A. H. (1995) · Immunity · doi:10.1016/1074-7613(95)90125-6 · Cited by 2,914
Lymphoproliferative Disorders with Early Lethality in Mice Deficient in Ctla-4
Waterhouse, P., Penninger, J. M., Timms, E., Wakeham, A., Shahinian, A., Lee, K. P., Thompson, C. B., Griesser, H., & Mak, T. W. (1995) · Science · doi:10.1126/science.270.5238.985 · Cited by 2,766
CD28/B7 SYSTEM OF T CELL COSTIMULATION
Lenschow, D. J., Walunas, T. L., & Bluestone, J. A. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.233 · Cited by 2,717
The Immunoglobulin Superfamily: Domains For Cell Surface Recognition
Williams, A. (1988) · Annual Review of Immunology · doi:10.1146/annurev.immunol.6.1.381 · Cited by 2,254
CTLA-4 can function as a negative regulator of T cell activation
Walunas, T. L., Lenschow, D. J., Bakker, C. Y., Linsley, P. S., Freeman, G. J., Green, J. M., Thompson, C. B., & Bluestone, J. A. (1994) · Immunity · doi:10.1016/1074-7613(94)90071-x · Cited by 2,222
MacLennan, I. C. M. (1994) · Annual Review of Immunology · doi:10.1146/annurev.immunol.12.1.117 · Cited by 1,729
A new member of the immunoglobulin superfamily—CTLA-4
Brunet, J.-F., Denizot, F., Luciani, M.-F., Roux-Dosseto, M., Suzan, M., Mattei, M.-G., & Golstein, P. (1987) · Nature · doi:10.1038/328267a0 · Cited by 1,306
Differential T Cell Costimulatory Requirements in CD28-Deficient Mice
Shahinian, A., Pfeffer, K., Lee, K. P., Kündig, T. M., Kishihara, K., Wakeham, A., Kawai, K., Ohashi, P. S., Thompson, C. B., & Mak, T. W. (1993) · Science · doi:10.1126/science.7688139 · Cited by 1,257
Rosenfeld, J., Capdevielle, J., Guillemot, J. C., & Ferrara, P. (1992) · Analytical Biochemistry · doi:10.1016/0003-2697(92)90061-b · Cited by 1,239 · cited 1×
“Protein material from five gels was pooled, in situ -digested with trypsi”
Method
Cited by
Items 701–800 of 1,001
Augmented ICOS expression in patients with early diffuse cutaneous systemic sclerosis
Hasegawa, M., Fujimoto, M., Matsushita, T., Hamaguchi, Y., & Takehara, K. (2012) · Rheumatology · doi:10.1093/rheumatology/kes258 · Cited by 30
Cellular and molecular profiling of T-cell subsets at the onset of human acute GVHD
Latis, E., Michonneau, D., Leloup, C., Varet, H., de Latour, R. P., Bianchi, E., Socié, G., & Rogge, L. (2020) · Blood Advances · doi:10.1182/bloodadvances.2019001032 · Cited by 30
“Delay sample-graft, median (range), d Donors 227 (2136 to 0) 227 (2119 to 21) GVHD onset 29 (12-91) 36 (9-94) No GVHD 91 (27-108) 90 (77-95) GVHD prophylaxis CSA 7 (18.”
Lee, B. J., Reiter, S. K., Anderson, M., & Sarawar, S. R. (2002) · Journal of Virology · doi:10.1128/jvi.76.6.3049-3053.2002 · Cited by 30
Costimulatory molecules and T-cell–B-cell interactions
Crow, M. K. (2004) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(03)00111-x · Cited by 31
“Inducible costimulator (ICOS) is a T-cell surface molecule that is related to CD28; its ligand (ICOSL; also called LICOS or B7-H2) is expressed on APCs and peripheral tissues [18–20].”
BackgroundT cell costimulatory pathways: blockade for autoimmunity
Najafian, N., & Khoury, S. J. (2003) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.3.2.227 · Cited by 34
Ligand Binding Sites of Inducible Costimulator and High Avidity Mutants with Improved Function
Wang, S., Zhu, G., Tamada, K., Chen, L., & Bajorath, J. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011607 · Cited by 30
AILIM/ICOS: Its Expression and Functional Analysis with Monoclonal Antibodies
Sakamoto, S., Tezuka, K., Tsuji, T., Hori, N., & Tamatani, T. (2001) · Hybridoma and Hybridomics · doi:10.1089/15368590152740699 · Cited by 31
T cell-mediated immune responses in melanoma: implications for immunotherapy
Wang, R., Zeng, G., Johnston, S. F., Voo, K., & Ying, H. (2002) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(01)00186-x · Cited by 30
“For example, inducible costimulator and B7related protein-1 (ICOS), a CD28-like molecule, enhances T cell proliferation, and secretion of cytokines [123].”
BackgroundBeier, K. C., Hutloff, A., Löhning, M., Kallinich, T., Kroczek, R. A., & Hamelmann, E. H. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.06.024 · Cited by 30
Self-citationOmar, H. A., & Tolba, M. F. (2019) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2019.01.009 · Cited by 32
Lung Cancer Immunotherapy: Beyond Common Immune Checkpoints Inhibitors
Catalano, M., Shabani, S., Venturini, J., Ottanelli, C., Voltolini, L., & Roviello, G. (2022) · Cancers · doi:10.3390/cancers14246145 · Cited by 32
Nagamatsu, T., Barrier, B. F., & Schust, D. J. (2010) · Immunology and Cell Biology · doi:10.1038/icb.2010.101 · Cited by 29
Sakiyama, H., Kobayashi, S., Dianzani, U., Ogiuchi, H., Kawashima, M., Uchiyama, T., & Yagi, J. (2008) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2007.12.010 · Cited by 29
ICOS Signaling Controls Induction and Maintenance of Collagen-Induced Arthritis
Panneton, V., Yazdchi, S. B., Witalis, M., Chang, J., & Suh, W. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1701305 · Cited by 32
Klingenberg, R., Autschbach, F., Gleissner, C. A., Giese, T., Wambsganss, N., Sommer, N., Richter, G. H. S., Katus, H. A., & Dengler, T. J. (2005) · European Journal of Immunology · doi:10.1002/eji.200425727 · Cited by 29
Burt, R. K., Slavin, S., Burns, W. H., & Marmont, A. M. (2002) · International Journal of Hematology · doi:10.1007/bf03165251 · Cited by 30
Zhang, G., Chen, Y., Shi, Q., Ma, H.-B., Ge, Y., Wang, Q., Jiang, Z., Xu, Y., & Zhang, X. (2004) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/36.6.430 · Cited by 29
New developments in immunosuppressive therapy in renal transplantation
Gourishankar, S., Turner, P., & Halloran, P. F. (2002) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2.5.483 · Cited by 29
The role of costimulatory molecules as targets for new immunosuppressives in transplantation
Kishimoto, K., Dong, V. M., & Sayegh, M. H. (2000) · Current Opinion in Urology · doi:10.1097/00042307-200003000-00002 · Cited by 29
Grozdics, E., Berta, L., Bajnok, A., Veres, G., Ilisz, I., Klivènyi, P., Rigó, J. J., Vécsei, L., Tulassay, T., & Toldi, G. (2014) · BMC Pregnancy and Childbirth · doi:10.1186/1471-2393-14-306 · Cited by 28
Tesciuba, A. G., Shilling, R. A., Agarwal, M. D., Bandukwala, H. S., Clay, B. S., Moore, T. V., Weinstock, J. V., Welcher, A. A., & Sperling, A. I. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.2.1019 · Cited by 29
Quispel, W. T., Stegehuis-Kamp, J. A., Santos, S. J., Egeler, R. M., & van Halteren, A. G. S. (2015) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2014.0190 · Cited by 28
Rojo, J. M., Pini, E., Ojeda, G., Bello, R., Dong, C., Flavell, R. A., Dianzani, U., & Portolés, P. (2008) · International Immunology · doi:10.1093/intimm/dxn016 · Cited by 28
Mak, T. W., & Saunders, M. E. (2006) · Elsevier eBooks · doi:10.1016/b978-012088451-3.50016-8 · Cited by 28
Burlion, A., Brunel, S., Petit, N. Y., Olive, D., & Marodon, G. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00756 · Cited by 28
Expression of ICOSL is associated with decreased survival in invasive breast cancer
Wang, B., Jiang, H., Zhou, T., Ma, N., Liu, W., Wang, Y., & Zuo, L. (2019) · PeerJ · doi:10.7717/peerj.6903 · Cited by 30
“Its counter ligand inducible co-stimulator ligand (ICOSL) can be found in professional APCs such as dendritic cells (DCs), B lymphocytes, as well as some cancer cells (e.g., implantedtransfected tumors) (Aspord et al., 2013; Le et al., 2016; Martin-Orozco et al., 2010; Schreiner et al., 2003; Wang et al., 2012).”
BackgroundInfluentialNew B7 Family Members with Positive and Negative Costimulatory Function
Rietz, C., & Chen, L. (2003) · American Journal of Transplantation · doi:10.1046/j.1600-6143.2003.00303.x · Cited by 28
ICOS limits memory-like properties and function of exhausted PD-1 + CD8 T cells
Humblin, É., Korpas, I., Prokhnevska, N., Vaidya, A. B., Filipescu, D., Lu, J., van der Heide, V., Fraga, C. A. D. C., Bobrowski, T., Marks, A. R., et al. (2024) · Immunity · doi:10.1016/j.immuni.2025.06.001 · Cited by 28
Coinhibitory molecules in cancer biology and therapy
Mocellin, S., Benna, C., & Pilati, P. (2013) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2013.01.003 · Cited by 28
“Finally, the frequency of CD4 T-cells expressing inducible costimulator (ICOS, a costimulatory molecule expressed on CD4 and CD8 T-cells following TCRmediated activation [59]) increases in patients treated with ipilimumab as compared to untreated melanoma patients or healthy volunteers, the occurrence being associated…”
BackgroundMoyo, N. A., Marchi, E., & Steinbach, F. (2013) · Immunology · doi:10.1111/imm.12094 · Cited by 30
Chester, C., Marabelle, A., Houot, R., & Kohrt, H. E. K. (2015) · Current Opinion in Immunology · doi:10.1016/j.coi.2014.12.010 · Cited by 28
Peyster, E. G., Wang, C., Ishola, F., Remeniuk, B., Hoyt, C. C., Feldman, M. D., & Margulies, K. B. (2020) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2020.01.015 · Cited by 27
“Whereas our present work closely resembles the early in situ research that elucidated the role of checkpoint molecules in tumor tissues (50), future efforts should also focus on characterizing which allograft antigens play a role in determining the allograft fate via T-cell receptor sequencing.”
ResultOrvain, C., Cauvet, A., Prudent, A., Guignabert, C., Thuillet, R., Ottaviani, M., Tu, L., Duhalde, F., Nicco, C., Batteux, F., et al. (2022) · Arthritis Research & Therapy · doi:10.1186/s13075-021-02709-2 · Cited by 28
“Signalling through CD28 and ICOS leads to T cell cytoskeletal remodelling, production of cytokines, enhanced survival, and differentiation [8, 9].”
BackgroundRe-Annotation Is an Essential Step in Systems Biology Modeling of Functional Genomics Data
van den Berg, B. H. J., McCarthy, F., Lamont, S. J., & Burgess, S. C. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010642 · Cited by 33
House dust mite‐specific T cells in healthy non‐atopic children
Bullens, D. M. A., Swerdt, A. D., Dilissen, E., Kasran, A., Kroczek, R. A., Cadot, P., Casaer, P., & Ceuppens, J. L. (2005) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2005.02352.x · Cited by 27
Self-citationRole of T cells in a gp91phox knockout murine model of acute allergic asthma
Banerjee, E. R., & Henderson, W. R. (2013) · Allergy Asthma and Clinical Immunology · doi:10.1186/1710-1492-9-6 · Cited by 28
Zhu, H., Hu, M., Wang, D., Xu, G., Yin, X., Liu, X., Ding, M., & Li, H. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110049 · Cited by 27
Checkpoint: Inspecting the barriers in glioblastoma immunotherapies
Preddy, I., Nandoliya, K. R., Miska, J. M., & Ahmed, A. U. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.02.012 · Cited by 29
Chen, X.-L., Cao, X., Kang, A.-J., Wang, K.-M., Su, B., & Wang, Y.-L. (2003) · World Journal of Gastroenterology · doi:10.3748/wjg.v9.i6.1370 · Cited by 27
Targeting Costimulatory Pathways for Tumor Immunotherapy
Ward, R. C., & Kaufman, H. L. (2007) · International Reviews of Immunology · doi:10.1080/08830180701365941 · Cited by 27
ICOS: A New Costimulatory Ligand/Receptor Pair and Its Role in T-Cell Activion
Richter, G. H. S., & Burdach, S. E. G. (2004) · Oncology Research and Treatment · doi:10.1159/000075612 · Cited by 27
Vidric, M., Suh, W., Dianzani, U., Mak, T. W., & Watts, T. H. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.11.7288 · Cited by 27
Leconte, J., Yazdchi, S. B., Panneton, V., & Suh, W. (2016) · Molecular Immunology · doi:10.1016/j.molimm.2016.09.022 · Cited by 30
Emerson, D. A., & Redmond, W. L. (2018) · BioDrugs · doi:10.1007/s40259-018-0277-2 · Cited by 27
“ICOS (CD278) is an immunoglobulin superfamily receptor expressed on activated T cells [97].”
Cannon, A. S., Holloman, B. L., Wilson, K. M., Miranda, K., Dopkins, N., Nagarkatti, P. S., & Nagarkatti, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.899609 · Cited by 26
“Both Rgs1, a gene that has been shown to influence migration, reduce the frequency of T follicular helper cells upon knockdown, and play a role in autoimmunity (39), and Icos, whose involvement in T cell activation was discovered in 1999 (40), were downregulated in the groups exposed to ConA+Veh when compared to Naïve…”
ResultPurcarea, A., Jarosch, S., Barton, J., Grassmann, S. A., Pachmayr, L. O., D’Ippolito, E., Hammel, M., Hochholzer, A., Wagner, K. I., van den Berg, J. H., et al. (2022) · Science Immunology · doi:10.1126/sciimmunol.abm2077 · Cited by 27
“However, high expression levels of surface proteins whose presence are known to be associated with T cell activation [such as PD-1, CD226 (70), CD82 (71), CD39 (71), or ICOS (inducible T-cell co-stimulator) (72, 73)] proved to consistently enrich for functional TCRs, whereas high expression levels of surface proteins…”
BackgroundChen, Q., Cannons, J. L., Paton, J. C., Akiba, H., Schwartzberg, P. L., & Snapper, C. M. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.12.8258 · Cited by 26
Loss of Immune Tolerance Is Controlled by ICOS in Sle1 Mice
Mittereder, N., Kuta, E. G., Bhat, G., Dacosta, K., Cheng, L., Herbst, R., & Carlesso, G. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1502241 · Cited by 28
B Cell Aberrance in Lupus: the Ringleader and the Solution
Nie, Y., Zhao, L., & Zhang, X. (2021) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-020-08820-7 · Cited by 26
Ruth, J. H., Rottman, J. B., Kingsbury, G. A., Coyle, A. J., Haines, G. K., Pope, R. M., & Koch, A. E. (2007) · Cytometry Part A · doi:10.1002/cyto.a.20383 · Cited by 26
Inhibitory costimulation and anti-tumor immunity
Martín‐Orozco, N., & Dong, C. (2007) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2007.06.003 · Cited by 26
Zeller, G. C., Hirahashi, J., Schwarting, A., Sharpe, A. H., & Kelley, V. R. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005080802 · Cited by 26
Wang, D., ZHOU, D., Du, Q., Liang, Q., Wang, Q., Li, F., Wang, G., FAN, Q., Liu, B., Zhou, J., et al. (2013) · Molecular Medicine Reports · doi:10.3892/mmr.2013.1326 · Cited by 26
ICOS-B7 Homologous Protein Interactions Are Necessary for Mercury-Induced Autoimmunity
Zheng, Y., Jost, M., Gaughan, J. P., Class, R., Coyle, A. J., & Monestier, M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.5.3117 · Cited by 26
Boštík, P., Mayne, A. E., Villinger, F. J., Greenberg, K. P., Powell, J. D., & Ansari, A. A. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.1.506 · Cited by 27
Role of the ICOS-B7h Costimulatory Pathway in the Pathophysiology of Chronic Allograft Rejection
Kashizuka, H., Sho, M., Nomi, T., Ikeda, N., Kuzumoto, Y., Akashi, S., Tsurui, Y., Mizuno, T., Kanehiro, H., Yagita∥, H., et al. (2005) · Transplantation · doi:10.1097/01.tp.0000161665.35243.21 · Cited by 26
Hatano, R., Ohnuma, K., Otsuka, H., Komiya, E., Taki, I., Iwata, S., Dang, N. H., Okumura, K., & Morimoto, C. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1402143 · Cited by 27
The Role of Metalloproteinase ADAM17 in Regulating ICOS Ligand–Mediated Humoral Immune Responses
Marczynska, J., Ozga, A. J., Włodarczyk, A., Majchrzak-Gorecka, M., Kulig, P., Banaś, M., Michalczyk‐Wetula, D., Majewski, P., Hutloff, A., Schwarz, J., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302893 · Cited by 25
Self-citationICOS‐dependent stimulation of NKT cells by marginal zone B cells
Ziętara, N., Łyszkiewicz, M., Krueger, A., & Weiß, S. (2011) · European Journal of Immunology · doi:10.1002/eji.201041092 · Cited by 25
ICOS promotes IL-17 synthesis in colonic intraepithelial lymphocytes in IL-10−/− mice
Schaefer, J. S., Montufar‐Solis, D., Vigneswaran, N., & Klein, J. R. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0409238 · Cited by 28
ICOS ligand expression is essential for allergic airway hyperresponsiveness
Kadkhoda, K., Wang, S., Fan, Y., Qiu, H., Basu, S., Halayko, A. J., & Yang, X. (2011) · International Immunology · doi:10.1093/intimm/dxq476 · Cited by 25
T cell activation on a single-cell level in dielectrophoresis-based microfluidic devices
Kirschbaum, M., Jaeger, M. S., Schenkel, T., Breinig, T., Meyerhans, A., & Duschl, C. (2008) · Journal of Chromatography A · doi:10.1016/j.chroma.2008.06.036 · Cited by 25
Simone, R., Barbarat, B., Rabellino, A., Icardi, G., Bagnasco, M., Pesce, G., Olive, D., & Saverino, D. (2010) · Molecular Immunology · doi:10.1016/j.molimm.2010.09.005 · Cited by 25
Normal ICOS, ICOSL and AID Alleles in Danish Patients with Common Variable Immunodeficiency
Ohm‐Laursen, L., Schjebel, L., Jacobsen, K., Permin, H., Svejgaard, A., & Barington, T. (2005) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2005.001603.x · Cited by 25
Huang, S., Tsai, H.-F., Tzeng, H.-T., Liao, H., & Hsu, P. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001092 · Cited by 25
Scales, H. E., Ierna, M. X., Gutierrez-Ramos, J.-C., Coyle, A. J., Garside, P., & Lawrence, C. E. (2004) · European Journal of Immunology · doi:10.1002/eji.200324364 · Cited by 25
Pawelec, G., Mariani, E., Bradley, B., & Solana, R. (2000) · Biogerontology · doi:10.1023/a:1010086229931 · Cited by 28
“Unlike costimulation via CD28, costimulation via ICOS does not result in IL-2 production but markedly upregulates IL-10 production, commonly considered a suppressive cytokine (Hutloff et al. 1999).”
BackgroundCritical co-stimulatory pathways in the stability of Foxp3+ Treg cell homeostasis in Type I Diabetes
Kornete, M., & Piccirillo, C. A. (2011) · Autoimmunity Reviews · doi:10.1016/j.autrev.2011.08.007 · Cited by 25
Abdel‐Rahman, S. A., Świderek, K., & Gabr, M. T. (2023) · RSC Medicinal Chemistry · doi:10.1039/d3md00150d · Cited by 24
CD4⁺Foxp3⁺ Treg and its ICOS⁺ subsets in patients with myocardial infarction.
Ghorbani, S., Andalib, A., Hashemi, M., & Rezaei, A. (2012) · PubMed · doi:10.22034/iji.2012.16857 · Cited by 24
T cell costimulation and coinhibition: genetics and disease.
Scandiuzzi, L., Ghosh, K., & Zang, X. (2011) · PubMed · Cited by 27
ICOS deficiency hampers the homeostasis, development and function of NK cells
Montes‐Casado, M., Ojeda, G., Aragoneses-Fenoll, L., López, D., de Andrés, B., Gaspar, M.-L., Dianzani, U., Rojo, J. M., & Portolés, P. (2019) · PLoS ONE · doi:10.1371/journal.pone.0219449 · Cited by 26
Host immunology and rational immunotherapy for carbapenem-resistant Klebsiella pneumoniae infection
Iwanaga, N., Sandquist, I., Wanek, A. G., McCombs, J. E., Song, K., & Kolls, J. K. (2020) · JCI Insight · doi:10.1172/jci.insight.135591 · Cited by 24
“ICOS is one of the CD28 family of costimulatory molecules and is highly expressed on the activated T cell (30, 31), especially type 2 helper T cells (32) and ILC2 (33), contributing to the isotype switch and germinal center formation (34).”
BackgroundDetailed bladder cancer immunoprofiling reveals new clues for immunotherapeutic strategies
Viveiros, N., Flores, B. C. T., Lobo, J., Martins‐Lima, C., Cantante, M., Lopes, P., Deantonio, C., Palu, C. C., Sainson, R. C. A., Henrique, R., et al. (2022) · Clinical & Translational Immunology · doi:10.1002/cti2.1402 · Cited by 24
“PD-1, ICOS is a costimulatory molecule that enhances T cells function.(15,16) Thus, ICOS endures both anti- and pro-tumor activities, depending on the T-cell subpopulation.”
BackgroundNouailles, G., Day, T. A., Kuhlmann, S., Löwe, D., Dorhoi, A., Gamradt, P., HURWITZ, R. M., Jörg, S., Pradl, L., Hutloff, A., et al. (2011) · European Journal of Immunology · doi:10.1002/eji.201040608 · Cited by 27
Self-citationDifferential induction of IL-17, IL-10, and IL-9 in human T helper cells by B7h and B7.1
Mesturini, R., Gigliotti, C. L., Orilieri, E., Cappellano, G., Soluri, M. F., Boggio, E. M., Woldetsadik, A. D., Dianzani, C., Sblattero, D., Chiocchetti, A., et al. (2013) · Cytokine · doi:10.1016/j.cyto.2013.05.021 · Cited by 27
Brix, S., Lund, P., Kjær, T., Straarup, E. M., Hellgren, L. I., & Frøkiær, H. (2009) · Immunology · doi:10.1111/j.1365-2567.2009.03163.x · Cited by 24
Cytokines in the Germinal Center Niche
Jandl, C., & King, C. (2016) · Antibodies · doi:10.3390/antib5010005 · Cited by 26
PD-1 blockade augments humoral immunity through ICOS-mediated CD4+ T cell instruction
Zhang, M., Xia, L., Yang, Y., Liu, S., Ji, P., Wang, S., Chen, Y., Liu, Z., Zhang, Y., Lü, S., et al. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.10.045 · Cited by 24
Fastrès, A., Pirottin, D., Fiévez, L., Marichal, T., Desmet, C. J., Bureau, F., & Clercx, C. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01707 · Cited by 26
Identification of CD4+ T cells with T follicular helper cell characteristics in the pig
Hoog, A., Villanueva-Hernández, S., Razavi, M. A., van Dongen, K., Eder, T., Piney, L., Chapat, L., Luca, K. D., Grebien, F., Mair, K. H., et al. (2022) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2022.104462 · Cited by 23
Roles of type 1 regulatory T (Tr1) cells in allergen-specific immunotherapy
Matsuda, M., Terada, T., Kitatani, K., Kawata, R., & Nabe, T. (2022) · Frontiers in Allergy · doi:10.3389/falgy.2022.981126 · Cited by 24
Activation Markers on B and T Cells and Immune Checkpoints in Autoimmune Rheumatic Diseases
Герасимова, Е. В., Tabakov, D., Gerasimova, D. A., & Попкова, Т. В. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158656 · Cited by 23
ICOS costimulation is indispensable for the differentiation of T follicular regulatory cells
Panneton, V., Mindt, B. C., Bouklouch, Y. C., Bouchard, A., Mohammaei, S., Chang, J., Diamantopoulos, N., Witalis, M., Li, J., Stancescu, A., et al. (2023) · Life Science Alliance · doi:10.26508/lsa.202201615 · Cited by 25
“The inducible costimulator (ICOS) is a member of the CD28 superfamily and is known to be expressed by activated T cells (Hutloff et al, 1999).”
Targeting Cytotoxic T-Lymphocyte Antigen 4 in Immunotherapies for Melanoma and Other Cancers
Page, D. B., Yuan, J. D., & Wolchok, J. D. (2010) · Immunotherapy · doi:10.2217/imt.10.21 · Cited by 23
B cells are required for sunlight protection of mice from a CNS-targeted autoimmune attack
Kok, L., Marsh‐Wakefield, F., Marshall, J. E., Gillis, C. M., Halliday, G. M., & Byrne, S. N. (2016) · Journal of Autoimmunity · doi:10.1016/j.jaut.2016.05.016 · Cited by 24
Fromm, G. J., de Silva, S., Giffin, L., Xu, X., Rose, J., & Schreiber, T. H. (2016) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-15-0228 · Cited by 23
Wang, Y., Hou, C., Wisler, J., Singh, K., Wu, C., Xie, Z., Lu, Q., & Zhou, Z. (2018) · Journal of Diabetes Investigation · doi:10.1111/jdi.12867 · Cited by 23
The Role of Immune Checkpoint Receptors in Regulating Immune Reactivity in Lupus
Lu, K., Wu, M.-Y., Wang, C., Wang, C., Chung, W., Chung, W., & Chen, C. (2019) · Cells · doi:10.3390/cells8101213 · Cited by 25
“It is expressed after the activation of naive T cells, which is dependent on prior CD28 signaling [26,27].”
BackgroundVathiotis, I. A., Johnson, J. M., & Argiris, A. E. (2021) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2021.102192 · Cited by 24
Requirement for CD28 in the Effector Phase of Allergic Airway Inflammation
Kimzey, S. L., Liu, P., & Green, J. M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.1.632 · Cited by 23
ICOS gene haplotypes correlate with IL10 secretion and multiple sclerosis evolution
Castelli, L., Comi, C., Chiocchetti, A., Nicola, S., Mesturini, R., Giordano, M., D’Alfonso, S., Cerutti, E., Galimberti, D., Fenoglio, C., et al. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2007.03.022 · Cited by 24
Zuberek, K., Ling, V., Wu, P. W., Ma, H., Leonard, J. P., Collins, M. A., & Dunussi‐Joannopoulos, K. (2003) · Cellular Immunology · doi:10.1016/j.cellimm.2003.09.002 · Cited by 23
A critical role for ICOS co‐stimulation in immune containment of pulmonary influenza virus infection
Humphreys, I. R., Edwards, L., Snelgrove, R. J., Rae, A. J., Coyle, A. J., & Hussell, T. (2006) · European Journal of Immunology · doi:10.1002/eji.200636155 · Cited by 23
McGee, H. S., Edwan, J. H., & Agrawal, D. K. (2009) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2008-0397oc · Cited by 24
Effects of Salmonella on spatial-temporal processes of jejunal development in chickens
Schokker, D., Smits, M. A., Hoekman, A. J. W., Parmentier, H. K., & Rebel, J. M. J. (2010) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2010.05.013 · Cited by 25
Usui, Y., Akiba, H., Takeuchi, M., Kezuka, T., Takeuchi, A., Hattori, T., Okunuki, Y., Yamazaki, T., Yagita∥, H., Usui, M., et al. (2006) · European Journal of Immunology · doi:10.1002/eji.200636138 · Cited by 23
Lee, W., Zhu, Q., Gambine, E., Jin, Y., Welcher, A. A., & Ochs, H. D. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(03)02021-9 · Cited by 23
de Goeje, P. L., Klaver, Y., Kaijen-Lambers, M. E. H., Langerak, A. W., Vroman, H. H., Kunert, A., Lamers, C. H. J., Aerts, J. G. J. V., Debets, R., & Hendriks, R. W. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02034 · Cited by 22
“This signifies T cell activation, because T cells upregulate HLA-DR (24), ICOS (25) and PD-1 (26) after (TCR) stimulation.”
BackgroundWang, Y., Li, J., Ma, C., Jiang, S., Li, C., Zhang, L., & Zhang, J. (2021) · Food & Function · doi:10.1039/d1fo01388b · Cited by 22
Metadata
- Authors
- Hutloff, A., Dittrich, A. M., Beier, K. C., Eljaschewitsch, B., Kraft, R., Anagnostopoulos, I., & Kroczek, R. A.
- Affiliations
- Robert Koch Institute (DE)
- Max Delbrück Center (DE)
- Freie Universität Berlin (DE)
- Corresponding author
- Kroczek, Richard A.
- Venue
- Nature
- Published
- 1999-01
- Volume
- 397
- Issue
- 6716
- Pages
- 263-266
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1661441964
- Cited by
- 1,482
- References
- 30
- Citations by year
- 2026: 28 · 2025: 38 · 2024: 52 · 2023: 41 · 2022: 66 · 2021: 54 · 2020: 60 · 2019: 53 · 2018: 52 · 2017: 32 · 2016: 44 · 2015: 41 · 2014: 35 · 2013: 53 · 2012: 47
- FWCI
- 22.57
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- ICOS, CD28, CTLA-4, T cell costimulation, T cell proliferation, lymphokine secretion, IL-10, B cell help, germinal center, adaptive immune regulation
- MeSH terms
- Amino Acid Sequence, Animals, Antibodies, Monoclonal, Antigens, Differentiation, T-Lymphocyte, Cell Communication, Cell Line, Cloning, Molecular, Humans, Lymphocyte Activation, Mice, Inbred BALB C, Molecular Sequence Data, T-Lymphocytes, CD28 Antigens, Germinal Center, Mice, Inducible T-Cell Co-Stimulator Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.